Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to evaluate the effect of omega 3 fatty acid on neurological recovery, lipid profile and Antioxidant system in patients with spinal cord injury. One hundred spinal cord injured patients who come to clinic of spinal injury repair research center selected. Then the patients will receive two supplements capsules of omega 3 (600 mg) in the intervention group and placebo in the control group. Primary outcome measures are professionals evaluation of neurological function by using :
Lipid profile and Antioxidant profile evaluation by using:
All no neurological evaluation will be done by experiment researcher under considering of a neurologist.All Sub clinical evaluation will be done by specific, sensitive and valid laboratory methods. Intervention time will be 14 months.Comparison of these variables will be done before and after intervention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| w3 supplement + capsule CA-D | Experimental | Mor DHA :w3 supp will be given to this group + capsule Ca(500 mg)-D(200 micro gram) |
|
| placebo+ CA-D | Placebo Comparator | placebo in the same color,shape,size |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| w3 supplement in SCI | Dietary Supplement | supplements(Mor DHA and Ca "500 mg" -D200 micro g" )( will be given in this group |
|
| Measure | Description | Time Frame |
|---|---|---|
| Neurological recovery,metabolic profile and Antioxidant profile evaluation | Primary outcome measures are professionals evaluation of neurological function by using :
| 4 months |
| Neurological recovery,metabolic profile and Antioxidant profile evaluation in SCI patients | ASIA scale for sensory and motor function FIM scale for Functional potential FAM SF36 for quality of life by using: FBS 2hpp Insulin LDL Total cHOL TG HDL Leptin Adiponectin -Calcium- 25OHD PTH,LH, FSH, Prolactin,Testosterone in males | 14 months |
| Measure | Description | Time Frame |
|---|---|---|
| Neurological recovery,metabolic profile and Antioxidant profile evaluation in patients with SCI | BMD : Femur and Lumbar | 14 months |
Not provided
Inclusion Criteria: no metabolic, malignant or kidney disorder, normal TSH, LH, FSH, prolactin, and testosterone in men and normal prolactin, estradiol, LH, FSH, and TSH in women
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Abbas Nouroozi, Ph.D | Brain and Spinal Cord Injury Repair Research Center | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Brain and Spinal Injury Repair Research Center | Tehran | Iran |
Not provided
| ID | Term |
|---|---|
| D052439 | Lipid Metabolism Disorders |
| ID | Term |
|---|---|
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| placebo | Other | placebo+ capsule CA-D |
|